DK453387A - Middel til behandling af arteriosklerose og forhindring af blodpladekoagulation - Google Patents

Middel til behandling af arteriosklerose og forhindring af blodpladekoagulation

Info

Publication number
DK453387A
DK453387A DK453387A DK453387A DK453387A DK 453387 A DK453387 A DK 453387A DK 453387 A DK453387 A DK 453387A DK 453387 A DK453387 A DK 453387A DK 453387 A DK453387 A DK 453387A
Authority
DK
Denmark
Prior art keywords
arteryos
sclerosis
prevention
agent
treatment
Prior art date
Application number
DK453387A
Other languages
English (en)
Other versions
DK453387D0 (da
Inventor
Ryuji Niwa
Nobuya Katagiri
Tetsuzo Kato
Yoshiyasu Shitori
Jiro Horiuchi
Original Assignee
Kanto Ishi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP61202357A external-priority patent/JPS6357522A/ja
Priority claimed from JP62187383A external-priority patent/JPS6431720A/ja
Application filed by Kanto Ishi Pharma Co Ltd filed Critical Kanto Ishi Pharma Co Ltd
Publication of DK453387D0 publication Critical patent/DK453387D0/da
Publication of DK453387A publication Critical patent/DK453387A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK453387A 1986-08-28 1987-08-28 Middel til behandling af arteriosklerose og forhindring af blodpladekoagulation DK453387A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61202357A JPS6357522A (ja) 1986-08-28 1986-08-28 ピリミド〔２，１−ｄ〕ベンゾチアゾ−ル誘導体からなる血小板凝集抑制剤
JP62187383A JPS6431720A (en) 1987-07-27 1987-07-27 Antihyperlipemic agent consisting of pyrimido(2,1-b)benzothiazole derivative

Publications (2)

Publication Number Publication Date
DK453387D0 DK453387D0 (da) 1987-08-28
DK453387A true DK453387A (da) 1988-02-29

Family

ID=26504322

Family Applications (1)

Application Number Title Priority Date Filing Date
DK453387A DK453387A (da) 1986-08-28 1987-08-28 Middel til behandling af arteriosklerose og forhindring af blodpladekoagulation

Country Status (9)

Country Link
EP (1) EP0261439B1 (da)
KR (1) KR900000293B1 (da)
CN (1) CN1016668B (da)
AT (1) ATE66812T1 (da)
AU (1) AU591419B2 (da)
CA (1) CA1297100C (da)
DE (1) DE3772687D1 (da)
DK (1) DK453387A (da)
NZ (1) NZ221579A (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3839839A1 (de) * 1988-11-25 1990-05-31 Henning Berlin Gmbh Mittel zur behandlung von chronisch entzuendlichen darmerkrankungen
US5484605A (en) * 1988-11-25 1996-01-16 Henning Berlin Gmbh Chemie-Und Pharmawerk Agent for treating chronically inflammatory intestinal diseases
DE4444930A1 (de) * 1994-12-16 1996-06-27 Cassella Ag 2-Amino-1,3-thiazepine und deren Verwendung als Hemmstoffe der Stickstoffmonoxid-Synthase
WO1997040051A1 (en) * 1996-04-24 1997-10-30 Takeda Chemical Industries, Ltd. Fused imidazopyridine derivatives as antihyperlipidemic agents
US5693641A (en) * 1996-08-16 1997-12-02 Berlex Laboratories Inc. Bicyclic pyrimidine derivatives and their use as anti-coagulants

Also Published As

Publication number Publication date
CN87105862A (zh) 1988-03-16
KR900000293B1 (ko) 1990-01-25
AU591419B2 (en) 1989-11-30
NZ221579A (en) 1990-04-26
DE3772687D1 (de) 1991-10-10
AU7743187A (en) 1988-03-03
EP0261439A3 (en) 1990-01-24
CA1297100C (en) 1992-03-10
ATE66812T1 (de) 1991-09-15
CN1016668B (zh) 1992-05-20
KR890003372A (ko) 1989-04-14
DK453387D0 (da) 1987-08-28
EP0261439A2 (en) 1988-03-30
EP0261439B1 (en) 1991-09-04

Similar Documents

Publication Publication Date Title
DK0428038T3 (da) Transdermal administration af 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
TW249226B (da)
NO910828L (no) Preparat for behandling av erektil funksjonssvikt.
IT9047580A0 (it) Procedimento di trattamento di polveri inorganiche.
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
ES2089136T3 (es) Tratamiento de enfermedades inflamatorias con la ayuda de derivados 15-ceto-prostaglandinas.
ATE132749T1 (de) Behandlung der hepatobilären erkrankung mit 15- ketoprostaglandin-derivaten
DK453387A (da) Middel til behandling af arteriosklerose og forhindring af blodpladekoagulation
ES2113345T3 (es) Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina.
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
AU569354B2 (en) (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
NO920983L (no) Fremgangsmaate for behandling av nevrodegenerative tilstander
DK0454429T3 (da) Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme
DE3683201D1 (de) Anwendung von ubidecarenon coenzym q10 zur behandlung von dekubitus.
DK160821C (da) 1,3-dihydro-4-benzoyl-2h-imidazol-2-oner samt middel til behandling af hjertesvigt
NO862454D0 (no) Fremgangsmaate for behandling av peroxydblekeavluter.
ATE90565T1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.
FI890065A0 (fi) Foerfarande foer framstaellning av 5,8,13, 14-tetrahydrobenz/5,6/isoindolo/2,1-b/isokinolin-8,13-dionderivat.
NO902968D0 (no) Fremgangsmaate for behandling av boreslam.
NO905643L (no) Fremgangsmaate for behandling av manganslam.
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.

Legal Events

Date Code Title Description
A0 Application filed
AHB Application shelved due to non-payment